NEW YORK--(BUSINESS WIRE)--Xalud Therapeutics, a clinical-stage biotechnology company developing DNA-delivered therapeutics, today announced the first patient dosed in a Phase 2a clinical trial of its ...
Osteoarthritis, that silent joint-eroding condition, affects millions across India, especially as people age. It's often associated with wear and tear, and the most commonly heard phrase that is said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results